Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 58151-58200 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT04363541
Local Thermotherapy for Patients With Mild-to-moderate COVID-19
NARecruiting
274 participants
Started: Aug 27, 2020 · Completed: Jun 30, 2022
2 conditions7 sponsors3 locations
NCT04210492
Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer
PHASE1/PHASE2Recruiting
36 participants
Started: Aug 26, 2020 · Completed: Jan 31, 2030
1 condition1 sponsor6 locations
NCT05697939
3D Body Surface Modeling for Scoliosis Monitoring
N/ARecruiting
13 participants
Started: Aug 26, 2020 · Completed: Jan 1, 2030
1 condition1 sponsor1 location
NCT04224064
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas
NARecruiting
158 participants
Started: Aug 26, 2020 · Completed: Dec 31, 2029
2 conditions1 sponsor1 location
NCT04915027
Rehabkompassen® - a Patient-centered Digital Follow-up Tool in the Post-stroke Continuum of Care
NARecruiting
1,106 participants
Started: Aug 26, 2020 · Completed: Dec 31, 2027
1 condition17 sponsors1 location
NCT06524427
Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)
NARecruiting
1,124 participants
Started: Aug 26, 2020 · Completed: Dec 31, 2030
1 condition24 sponsors24 locations
NCT04243720
Immune Resistance Interrogation Study
N/ARecruiting
100 participants
Started: Aug 26, 2020 · Completed: Feb 28, 2025
4 conditions1 sponsor1 location
NCT04850053
Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis
N/ARecruiting
1,500 participants
Started: Aug 26, 2020 · Completed: Dec 31, 2024
1 condition11 sponsors1 location
NCT05822427
Long-term Follow-up of Study Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product in an Imugene Ltd. Clinical Study
N/ARecruiting
75 participants
Started: Aug 25, 2020 · Completed: Dec 31, 2039
1 condition1 sponsor1 location
NCT04452162
Physiologic MR Imaging of Salivary Gland Tumors
NARecruiting
30 participants
Started: Aug 25, 2020 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT04614480
Exome Analysis (Complexe vs Simple) to Help the Therapeutic Decision for the Precision Medicine
PHASE2Recruiting
7,976 participants
Started: Aug 25, 2020 · Completed: Sep 2, 2032
1 condition1 sponsor12 locations
NCT04553523
Hydrus® Microstent New Enrollment Post-Approval Study
NARecruiting
545 participants
Started: Aug 25, 2020 · Completed: Jun 30, 2028
1 condition1 sponsor22 locations
NCT04505254
Acalabrutinib and Obinutuzumab for the Treatment of Chronic Lymphocytic Leukemia
PHASE2Recruiting
60 participants
Started: Aug 25, 2020 · Completed: Jun 30, 2027
2 conditions2 sponsors1 location
NCT04444492
Combination of Ranibizumab and Targeted Laser Photocoagulation
PHASE3Recruiting
110 participants
Started: Aug 25, 2020 · Completed: Nov 30, 2027
1 condition2 sponsors15 locations
NCT04185974
Carbon Ion Re-Radiotherapy in Patients With Recurrent or Progressive Locally Advanced Head-and-Neck Cancer
NARecruiting
72 participants
Started: Aug 25, 2020 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT04239157
A Phase II, Open-Label, Study of Subcutaneous Canakinumab, an Anti-IL-1β Human Monoclonal Antibody, for Patients With Low or Int-1 Risk IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
PHASE2Recruiting
76 participants
Started: Aug 25, 2020 · Completed: Dec 31, 2026
6 conditions3 sponsors1 location
NCT03898596
Umbilical Vessel Catheterization Under ECG Monitoring and Guidance
NARecruiting
150 participants
Started: Aug 25, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04514653
RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD) (AAVIATE)
PHASE2Recruiting
115 participants
Started: Aug 25, 2020 · Completed: Aug 1, 2026
1 condition1 sponsor15 locations
NCT04537286
First-line Nab-paclitaxel Plus Cisplatin Plus Carilizumab in mTNBC Patients
PHASE2Recruiting
90 participants
Started: Aug 25, 2020 · Completed: Oct 15, 2024
1 condition1 sponsor1 location
NCT04102371
Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis
PHASE3Recruiting
8,800 participants
Started: Aug 25, 2020 · Completed: Aug 31, 2026
2 conditions50 sponsors24 locations
NCT05335603
An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis
N/ARecruiting
335 participants
Started: Aug 24, 2020 · Completed: Aug 31, 2036
1 condition2 sponsors1 location
NCT04298255
Experimental Round Spermatid Injection (ROSI) to Treat Infertile Couples
NARecruiting
50 participants
Started: Aug 24, 2020 · Completed: Jul 31, 2026
1 condition4 sponsors1 location
NCT04449549
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
PHASE2Recruiting
82 participants
Started: Aug 24, 2020 · Completed: Apr 8, 2026
1 condition1 sponsor1 location
NCT06125444
Impact of Hyperuricemia on Psoriatic Arthritis
N/ARecruiting
242 participants
Started: Aug 24, 2020 · Completed: Dec 31, 2023
1 condition1 sponsor1 location
NCT04984551
Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
PHASE2Recruiting
312 participants
Started: Aug 24, 2020 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04341181
ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling
PHASE2Recruiting
300 participants
Started: Aug 24, 2020 · Completed: Apr 30, 2030
4 conditions4 sponsors7 locations
NCT04532268
A Study of Humanized CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell ALL and B-cell NHL
EARLY_PHASE1Recruiting
72 participants
Started: Aug 23, 2020 · Completed: Aug 23, 2026
2 conditions2 sponsors1 location
NCT04398862
Pulmonary Health in Children With Down Syndrome
N/ARecruiting
75 participants
Started: Aug 21, 2020 · Completed: Dec 30, 2024
2 conditions2 sponsors1 location
NCT04322370
Prospective Randomized Blinded Trial of VersaWrap Tendon Protector for Zone 2 Flexor Tendon Injuries
NARecruiting
42 participants
Started: Aug 21, 2020 · Completed: May 17, 2027
1 condition1 sponsor1 location
NCT04329494
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
PHASE1Recruiting
49 participants
Started: Aug 21, 2020 · Completed: Aug 5, 2026
27 conditions2 sponsors3 locations
NCT04502225
Effect of Raised Head of the Bed on Lying Blood Pressure in Autonomic Failure
NARecruiting
44 participants
Started: Aug 21, 2020 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04599218
MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer
NARecruiting
1,586 participants
Started: Aug 21, 2020 · Completed: Jan 15, 2026
5 conditions2 sponsors3 locations
NCT04343443
Acute Heart Failure With Reduced Ejection Fraction - COngestion Discharge Evaluation
NARecruiting
200 participants
Started: Aug 21, 2020 · Completed: Aug 21, 2028
1 condition1 sponsor1 location
NCT04632654
A Motion Exergaming Approach for Symptom Management: HNC
NARecruiting
150 participants
Started: Aug 21, 2020 · Completed: Nov 30, 2026
1 condition2 sponsors1 location
NCT04528355
Data Collection Study of Patients with Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT with RIC
N/ARecruiting
50 participants
Started: Aug 20, 2020 · Completed: Jun 30, 2026
5 conditions1 sponsor1 location
NCT04252781
Incident Chronic Obstructive pulmoNary dIsease Cohort Study (ICONIC)
NARecruiting
300 participants
Started: Aug 20, 2020 · Completed: Feb 20, 2026
2 conditions1 sponsor1 location
NCT04517487
Vaginal Microbiome Transplantation for Recurrent Bacterial Vaginosis
NARecruiting
100 participants
Started: Aug 20, 2020 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT04487314
Registry for Chronic Venous Disease Incidence and Natural Course
N/ARecruiting
10,000 participants
Started: Aug 20, 2020 · Completed: Sep 1, 2050
1 condition1 sponsor1 location
NCT04988009
Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
N/ARecruiting
200 participants
Started: Aug 20, 2020 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT04388332
ACDF Using Structural Allograft Vs. Tritanium C
NARecruiting
60 participants
Started: Aug 20, 2020 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT04675138
Development of a Clinical Decision Support System With Artificial Intelligence for Cancer Care
N/ARecruiting
1,000 participants
Started: Aug 20, 2020 · Completed: Dec 31, 2024
3 conditions1 sponsor9 locations
NCT04541446
Study Dynamic Haptic Robotic Trainer (DHRT) and DHRT+ for CVC Insertion Training for Surgical Residents
NARecruiting
625 participants
Started: Aug 19, 2020 · Completed: Jul 31, 2025
2 conditions2 sponsors2 locations
NCT04591639
The DAPA-MEMRI Trial
NARecruiting
160 participants
Started: Aug 19, 2020 · Completed: Jul 28, 2028
2 conditions3 sponsors1 location
NCT04490603
The Effect of Virtual Reality Experience on Infusion-related Pain
NARecruiting
72 participants
Started: Aug 19, 2020 · Completed: Dec 28, 2024
1 condition1 sponsor1 location
NCT04363164
Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
PHASE2Recruiting
150 participants
Started: Aug 19, 2020 · Completed: Jul 31, 2027
1 condition2 sponsors6 locations
NCT04332822
A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
PHASE3Recruiting
300 participants
Started: Aug 19, 2020 · Completed: Dec 28, 2028
2 conditions2 sponsors69 locations
NCT04513977
Geriatric Oncology SuPportive Clinic for ELderly
NARecruiting
200 participants
Started: Aug 19, 2020 · Completed: Sep 30, 2025
2 conditions3 sponsors1 location
NCT06201182
Efficacy of Fecal Microbiota Transplantation (FMT) in Irritable Bowel Syndrome (IBS)
NARecruiting
45 participants
Started: Aug 19, 2020 · Completed: Aug 19, 2024
1 condition1 sponsor1 location
NCT04419649
A Study of KER-050 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes
PHASE2Recruiting
140 participants
Started: Aug 19, 2020 · Completed: Oct 30, 2030
2 conditions1 sponsor43 locations
NCT04501705
Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults
NARecruiting
29 participants
Started: Aug 18, 2020 · Completed: Aug 31, 2025
1 condition1 sponsor1 location